First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Announces Quarterly Dividend of $0.01

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) announced a quarterly dividend on Wednesday, September 23rd. Investors of record on Thursday, September 24th will be given a dividend of 0.0113 per share on Wednesday, September 30th. This represents a c) annualized dividend and a dividend yield of 0.1%. The ex-dividend date is Thursday, September 24th.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.8%

FTXH stock traded up $0.35 during trading on Thursday, reaching $41.63. 3,001 shares of the stock were exchanged, compared to its average volume of 215,025. First Trust Nasdaq Pharmaceuticals ETF has a twelve month low of $27.30 and a twelve month high of $42.87. The company has a market capitalization of $1.20 billion, a P/E ratio of 14.51 and a beta of 0.46. The stock has a 50 day simple moving average of $40.45 and a 200-day simple moving average of $36.97.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Compass Financial Management LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter worth about $29,000. Nilsine Partners LLC increased its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock worth $1,071,000 after buying an additional 937 shares in the last quarter. Vivaldi Capital Management LP raised its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after acquiring an additional 1,741 shares during the last quarter. Finally, Flputnam Investment Management Co. bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the fourth quarter valued at approximately $230,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.